The Recombinant Drosophila persimilis Adenosine Monophosphate-Protein Transferase FICD Homolog (GL25530) is a protein derived from the fruit fly species Drosophila persimilis. This protein is a homolog of the FICD (Filamentation induced by cAMP domain) protein, which plays a role in the transfer of adenosine monophosphate (AMP) to target proteins, a process known as AMPylation. AMPylation is a post-translational modification that can alter protein function and is involved in various cellular processes.
FICD homologs, including the GL25530 protein, are enzymes that catalyze the transfer of AMP from ATP to target proteins. This modification can affect protein activity, localization, and interactions. In bacteria and eukaryotes, FICD proteins have been implicated in stress responses, cell signaling, and metabolic regulation. While specific functions of the GL25530 protein in Drosophila persimilis are not extensively documented, its homology to known FICD proteins suggests similar roles in cellular regulation.
The recombinant form of the GL25530 protein is produced through genetic engineering techniques, where the gene encoding this protein is expressed in a suitable host organism. This allows for large-scale production of the protein for research and potential therapeutic applications. Recombinant proteins are often used in biochemical assays, structural studies, and as tools for understanding protein function and interactions.
Property | Description |
---|---|
Protein Type | Adenosine Monophosphate-Protein Transferase |
Organism | Drosophila persimilis |
Function | AMPylation of target proteins |
Expression Form | Recombinant, His-tagged |
Potential Applications | Biochemical assays, structural studies |
Process | Description |
---|---|
Stress Response | Modification of proteins involved in stress signaling pathways |
Cell Signaling | Regulation of signaling proteins through AMPylation |
Metabolic Regulation | Influence on metabolic pathways by modifying key enzymes |
- Recombinant Full Length Drosophila Persimilis Adenosine Monophosphate-Protein Transferase FICD Homolog (Gl25530) Protein, His-Tagged.
General literature on FICD proteins and AMPylation processes.
This protein functions as a dual-acting enzyme, capable of both AMPylation (addition of adenosine 5'-monophosphate to target proteins) and de-AMPylation (removal of AMP from target proteins), depending on the cellular context. Glutamic acid 261 (Glu-261) in the protein's structure dictates whether AMPylation or de-AMPylation will occur. It plays a crucial regulatory role in the unfolded protein response (UPR) by modulating the AMPylation/de-AMPylation status of Hsc70-3/BiP. Under normal cellular conditions, it acts as an adenylyltransferase, AMPylating Hsc70-3/BiP at threonine 518 (Thr-518), thus inhibiting its activity. In response to endoplasmic reticulum stress, its function shifts to a phosphodiesterase, removing AMP from Hsc70-3/BiP at Thr-518, thereby restoring HSPA5/BiP activity.
KEGG: dpe:Dper_GL25530
The FICD homolog (GL25530) in Drosophila serves as an adenosine monophosphate-protein transferase that catalyzes the addition of adenosine monophosphate to target proteins . In the visual system of Drosophila, Fic domain-containing proteins play a critical role in neurotransmission, particularly in the recycling of the visual neurotransmitter histamine . Research has demonstrated that flies lacking Fic maintained normal photoreceptor cell depolarization following light stimulation but failed to activate postsynaptic neurons, resulting in blindness due to neurotransmission defects . The functional requirement of enzymatically active Fic occurs specifically in glial capitate projections rather than neurons themselves .
Fic domain proteins are evolutionarily conserved across species, with the Drosophila FICD homolog serving as an important model for understanding eukaryotic Fic function . While bacterial Fic domains have been well characterized in pathogenic mechanisms, the function of eukaryotic Fic domain proteins remained largely unknown until studies using Drosophila models provided significant insights . The Drosophila system offers a unique advantage for studying Fic domain proteins as it contains only a single Fic domain-containing protein, compared to the multiple homologs found in mammals . This simplifies genetic manipulation and functional characterization. The fundamental mechanisms of adenosine monophosphate transfer are conserved, but the physiological contexts and target substrates may differ between species .
For optimal expression of recombinant Drosophila persimilis FICD homolog (GL25530), the following protocol is recommended:
Expression System: E. coli is the preferred heterologous expression system for the full-length protein .
Construct Design: The protein should be designed with an N-terminal His tag for efficient purification .
Culture Conditions:
Growth temperature: 37°C until OD600 reaches 0.6-0.8
Induction: 0.5-1.0 mM IPTG
Post-induction temperature: 18-25°C for 16-20 hours
Purification Protocol:
The purified protein should yield greater than 90% purity as determined by SDS-PAGE analysis .
Several approaches can be employed to assess the adenosine monophosphate-protein transferase activity of FICD homolog:
Method | Application | Detection Limit | Advantages |
---|---|---|---|
Radioactive assay (32P-ATP) | Direct measurement of AMP transfer | 1-5 pmol | Highly sensitive, quantitative |
Mass spectrometry | Identification of AMP modification sites | Site-specific | Provides precise target identification |
Western blotting | Detection of AMPylated proteins | 0.1-1 ng | Antibody-based detection of modified proteins |
Fluorescence assays | Real-time monitoring of activity | 10-50 nM | Non-radioactive, continuous readout |
For in vitro activity assays, the recombinant protein should be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL, and storage with 5-50% glycerol is recommended for long-term maintenance of enzymatic activity . The catalytic activity requires ATP as a substrate and is typically measured by the transfer of AMP to target proteins, with subsequent detection of the modified proteins .
To generate and validate FICD knockout models in Drosophila for functional studies:
Generation Methods:
Validation Approaches:
Molecular verification:
PCR genotyping to confirm mutation
RT-qPCR to verify decreased mRNA expression
Western blot to confirm protein absence
Functional validation:
Rescue Experiments:
For rigorous validation, researchers should confirm not only the genetic modification but also the predicted functional defects, particularly in visual neurotransmission, which is a well-characterized phenotype of Fic deficiency in Drosophila .
The FICD homolog interacts with adenosine nucleotide metabolism through several interconnected pathways:
AMP Biosynthesis Pathway Interaction:
FICD utilizes ATP as a substrate for AMP transfer reactions
This activity influences cellular AMP:ATP ratios, which are critical signaling indicators of energy status
Alterations in adenosine nucleotide ratios can activate AMPK (adenosine monophosphate-activated protein kinase), a central regulator of cellular energy homeostasis
Regulatory Mechanisms:
FICD activity may be regulated by cellular adenine levels, similar to other adenosine nucleotide metabolism enzymes
In Drosophila, dietary adenine can influence AMP biosynthesis and subsequently affect lifespan through AMPK-dependent mechanisms
The AMP transfer activity of FICD potentially creates a feedback loop with cellular adenosine nucleotide pools
Physiological Impact:
Understanding these interactions provides insight into how FICD functions within the broader context of cellular energy metabolism and signaling pathways involving adenosine nucleotides .
The FICD homolog plays a crucial role in visual neurotransmission through its involvement in neurotransmitter recycling:
Glial Cell Function:
Histamine Recycling Mechanism:
Visual transmission in Drosophila relies on histamine as a neurotransmitter
FICD appears to regulate the recycling of histamine in the visual system
Flies lacking FICD show reduced histamine levels in the lamina of the visual system
This deficiency can be partially rescued by dietary histamine supplementation
Electrophysiological Phenotype:
Flies with FICD deficiency show normal photoreceptor cell depolarization but fail to activate postsynaptic neurons
This is evidenced by the loss of ON transients in electroretinograms, indicating a specific neurotransmission defect
The phenotype confirms that the primary role of FICD is in neurotransmitter signaling rather than in photoreceptor function itself
This specialized role in neurotransmitter recycling represents a previously unknown regulatory mechanism in visual neurotransmission and highlights the importance of glial cells in maintaining proper neuronal communication .
FICD homolog provides a valuable tool for studying protein AMPylation (the addition of AMP to proteins) across different physiological contexts:
Identification of Target Proteins:
Recombinant FICD can be used in proteome-wide screens to identify novel substrates for AMPylation
Methods include:
In vitro AMPylation assays with protein arrays
Affinity purification of AMPylated proteins followed by mass spectrometry
Proximity labeling approaches to identify proteins in the FICD interactome
Studying AMPylation in Stress Responses:
FICD activity can be monitored under various cellular stresses (oxidative, thermal, nutrient deprivation)
Changes in AMPylation patterns may represent a post-translational regulatory mechanism during stress
Drosophila models provide an excellent in vivo system to study stress-induced AMPylation across tissues and developmental stages
Cross-Species Comparative Studies:
Developmental Biology Applications:
Drosophila's rapid reproductive cycle (approximately 10 days from fertilization to adulthood) enables multi-generational studies of FICD function
Researchers can investigate the role of AMPylation in development, aging, and tissue homeostasis
The well-characterized Drosophila visual system provides a model for studying AMPylation in neural development and function
Utilizing recombinant FICD homolog for these studies requires careful experimental design, including controls for enzymatic activity and specificity of the AMPylation reaction.
For optimal stability and retention of enzymatic activity, recombinant FICD homolog requires specific storage and handling protocols:
Storage Condition | Recommendation | Notes |
---|---|---|
Short-term storage | 4°C for up to one week | For working aliquots in active use |
Long-term storage | -20°C/-80°C | Aliquoting is necessary to avoid freeze-thaw cycles |
Storage buffer | Tris/PBS-based buffer with 6% Trehalose, pH 8.0 | Trehalose acts as a cryoprotectant |
Reconstitution | Deionized sterile water to 0.1-1.0 mg/mL | Brief centrifugation prior to opening recommended |
Glycerol addition | 5-50% final concentration (50% recommended) | For freeze protection during long-term storage |
Additional handling considerations include:
Avoid repeated freeze-thaw cycles, which significantly reduce enzymatic activity
Briefly centrifuge vials prior to opening to bring contents to the bottom
Prepare small working aliquots to minimize exposure to room temperature
When preparing for experiments, thaw samples on ice rather than at room temperature
These precautions help maintain the structural integrity and enzymatic activity of the recombinant protein for experimental applications .
When encountering inactive or low-activity FICD protein preparations, researchers should systematically troubleshoot using the following approaches:
Protein Integrity Assessment:
Activity Optimization Strategies:
Buffer optimization: Test various pH conditions (range 7.0-8.5)
Divalent cation requirements: Include MgCl₂ or MnCl₂ (1-5 mM) which are often essential for Fic domain activity
Reducing agent addition: Try fresh DTT or β-mercaptoethanol (1-5 mM)
Substrate concentration adjustment: Titrate ATP concentrations (0.1-2 mM)
Protein Refolding Approaches:
For proteins expressed as inclusion bodies, try multiple refolding protocols
Dialysis against decreasing concentrations of denaturants
Step-wise reduction of urea or guanidinium hydrochloride
Expression System Alternatives:
If E. coli expression yields inactive protein, consider insect cell expression systems
Baculovirus expression in Sf9 or High Five cells may improve folding
Codon optimization for the expression system being used
Positive Control Validation:
Use a known substrate of FICD (if available) to validate activity assay conditions
Include a positive control sample of previously confirmed active FICD protein
By systematically addressing these aspects, researchers can identify and resolve issues affecting FICD protein activity in their experimental preparations.
Designing effective target identification experiments for FICD homolog requires careful consideration of several key factors:
Substrate Specificity Analysis:
Employ both candidate-based and unbiased screening approaches
Candidate approach: Test proteins involved in visual neurotransmission and histamine metabolism
Unbiased approach: Use proteome-wide screens with active FICD enzyme
Experimental Controls:
Enzymatically inactive FICD mutant (mutation in the Fic domain catalytic site)
ATP-free reactions to control for non-enzymatic protein interactions
Tissue-specific extracts (e.g., visual system components) for physiologically relevant targets
Detection Strategies:
Direct detection: Radioactive or fluorescent ATP analogs to track AMP transfer
Indirect detection: Anti-AMP-protein antibodies or chemical biology approaches
Mass spectrometry workflow:
Step | Method | Purpose |
---|---|---|
1 | In vitro AMPylation | Label potential targets using recombinant FICD |
2 | Enrichment | Isolate modified proteins via antibody pulldown |
3 | Digestion | Trypsin treatment to generate peptides |
4 | LC-MS/MS | Identify modified peptides and modification sites |
5 | Data analysis | Bioinformatic workflow to identify AMPylated proteins |
Validation in Biological Context:
Confirm targets in Drosophila tissues, particularly in the visual system
Use genetic approaches to test functional relationships:
Generate mutants of identified targets
Test for similar phenotypes to FICD mutants (visual neurotransmission defects)
Perform genetic interaction studies between FICD and target mutants
Comparative Analysis:
These considerations will help researchers design robust experiments to identify and validate the physiological targets of FICD homolog, particularly in the context of its role in visual neurotransmission and glial cell function.
FICD homolog research in Drosophila has significant potential to advance our understanding of neurodegenerative diseases through several mechanisms:
Neurotransmitter Recycling Pathways:
FICD's critical role in glial-mediated neurotransmitter recycling in Drosophila visual systems may have parallels in mammalian neurological disorders
Dysfunctional neurotransmitter recycling is implicated in conditions such as epilepsy, Alzheimer's disease, and Parkinson's disease
The Drosophila model offers a simplified system to study these conserved mechanisms
Glial-Neuronal Interactions:
FICD function in glial capitate projections represents a novel mechanism for glial regulation of neuronal activity
Aberrant glial-neuronal communication is increasingly recognized as central to neurodegenerative pathology
Investigating FICD-dependent protein modifications in glial cells could reveal new therapeutic targets
Protein Homeostasis and Aggregation:
Energy Metabolism in Neurodegeneration:
FICD's connection to adenosine nucleotide metabolism links to cellular energy sensing via AMPK pathways
Neurodegeneration often involves disrupted energy metabolism and mitochondrial dysfunction
Understanding how FICD influences adenosine nucleotide ratios may provide insights into metabolic aspects of neurodegeneration
Translational Research Potential:
Identification of FICD targets in Drosophila could lead to discovery of conserved mammalian targets relevant to neurodegeneration
High-throughput screening for modulators of FICD activity could identify compounds with therapeutic potential
Genetic rescue experiments in Drosophila models could validate intervention strategies before moving to more complex systems
The conserved nature of fundamental biological processes between Drosophila and humans makes these research directions particularly promising for translational applications in understanding and potentially treating neurodegenerative diseases .
Several cutting-edge technologies are poised to revolutionize studies of FICD homolog function:
CRISPR-Based Approaches:
CRISPR activation/inhibition (CRISPRa/CRISPRi) for tissue-specific and temporal control of FICD expression
Base editing for introducing specific mutations in the catalytic domain without disrupting the entire gene
Prime editing for precise modification of FICD to create activity-modulated variants
Advanced Imaging Technologies:
Super-resolution microscopy to visualize FICD localization in glial capitate projections
Expansion microscopy to physically enlarge Drosophila neural tissues for improved visualization
Live-cell AMPylation sensors to monitor FICD activity in real-time within intact tissues
Proteomics and Metabolomics Integration:
Quantitative interaction proteomics to map the FICD interactome under various conditions
Metabolomics analysis to track changes in adenosine nucleotide pools related to FICD activity
Combined multi-omics approaches to create comprehensive models of FICD function
Single-Cell Technologies:
Single-cell RNA sequencing to identify cell-type-specific responses to FICD deficiency
Single-cell proteomics to detect differential protein AMPylation patterns across cell types
Spatial transcriptomics to map gene expression changes in the visual system of FICD mutants
Computational and AI-Driven Approaches:
Machine learning algorithms to predict novel FICD substrates based on structural features
Molecular dynamics simulations to understand the mechanism of AMP transfer in atomic detail
Systems biology modeling to integrate FICD function into broader cellular networks
These technologies offer unprecedented opportunities to dissect FICD function with high spatial and temporal resolution, potentially uncovering new roles beyond its established function in visual neurotransmission .
Comparative studies across Drosophila species represent a powerful approach to understanding FICD evolution and function:
Evolutionary Conservation Analysis:
Sequence comparison of FICD homologs across Drosophila species (including D. persimilis and D. melanogaster) can identify:
Highly conserved domains crucial for enzymatic function
Species-specific variations that may relate to ecological adaptations
Selection pressures on different regions of the protein
Functional Divergence Assessment:
Cross-species complementation experiments:
Testing whether D. persimilis FICD can rescue visual phenotypes in D. melanogaster FICD mutants
Identifying species-specific differences in substrate recognition
The rapid reproductive cycle of Drosophila (approximately 10 days) facilitates these comparative studies
Ecological and Behavioral Correlations:
Different Drosophila species inhabit diverse ecological niches with varying visual demands
Comparative analysis can reveal how FICD function may have adapted to:
Different light environments
Varying needs for visual neurotransmission speed and efficiency
Species-specific behaviors that rely on visual processing
Regulatory Mechanism Comparison:
Analysis of promoter regions and regulatory elements of FICD across species
Investigation of tissue-specific expression patterns and their correlation with visual system anatomy
Examination of how FICD expression responds to environmental factors in different species
Integrative Approach:
Combining genomic, transcriptomic, and proteomic data across species
Creating a phylogenetic framework for understanding FICD functional evolution
Identifying convergent or divergent evolutionary pathways in visual system function
Such comparative studies can provide unique insights into both the fundamental conserved functions of FICD and the species-specific adaptations that may have evolved to meet particular ecological or physiological demands .